Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MDR1 in paroxetine-induced sexual dysfunction.

Journal of sex & marital therapy - 1 Jan 2013

Zourková Alexandra, Slanař Ondřej, Jarkovský Jiří, Palčíková Ivana, Pindurová Eva, Cvanová Michaela

Abstract excerpt

Paroxetine-induced sexual dysfunction represents a frequent treatment complication of otherwise efficient antidepressants. The genetic polymorphism of pharmacokinetic genes may contribute to the occurrence of such dysfunctions. This study presents the effect of MDR1 gene polymorphisms on sexual function in 18 women with bulimia nervosa, 18 women with anxiety disorders, and 19 healthy control subjects. It also...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Anxiety Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ATP Binding Cassette Transporter, Subfamily B

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Share to Bulimia Nervosa

Share to Case-Control Studies

Share to Polymorphism, Genetic

Share to Young Adult

Source

Identifiers

PMID: 23152970
DOI: 10.1080/0092623X.2012.668514

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MDR1 in paroxetine-induced sexual dysfunction.PMID 23152970Read ↗

Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.Semantic proximity Read ↗

Does G2677T Polymorphism of the MDR1 Gene Make a Difference in the Therapeutic Response to Paroxetine in Depressed Patients in a Slovakian Population?Semantic proximity Read ↗

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.Semantic proximity Read ↗

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.Semantic proximity Read ↗

Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women.Semantic proximity Read ↗

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness.Semantic proximity Read ↗

Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.Semantic proximity Read ↗

Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism.Semantic proximity Read ↗

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.Semantic proximity Read ↗

Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Semantic proximity Read ↗

Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.Semantic proximity Read ↗

Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.